All In MedTech

Device Trial Radar · NCT05376475

Sleep in Late Pregnancy - Artificial Intelligence Development for the Detection of Disturbances and Disorders

Sleep in Late Pregnancy - Artificial Intelligence Development for the Detection of Disturbances and Disorders (SLeeP AID4): An Observational, In-Home, Single-Group, Feasibility Study

Last checked: Nov 19, 2026Latest source record: Oct 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

60

Planned (sponsor's estimate)

Start

Jul 6, 2022

Primary completion

Jun 30, 2023

Study completion Jun 30, 2024

Sponsor

Lead sponsor
Shiphrah Biomedical Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Mitacs; University of Toronto
First posted
May 17, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

SLeeP AID4 is a single-group, single-arm, Canada-wide, non-randomised, unblinded, in-home, observational study to prospectively collect and build a data set of natural sleep behaviour and physiology in maternal-fetal dyads (and bed partners, if applicable) in the third trimester of pregnancy in the home setting and subsequently investigate the feasibility of using computer vision technology (CVT) to monitor sleep during and across the third trimester of pregnancy in the home setting for research purposes by eliciting participants' attitudes toward CVT and training, validating, and testing a CVT model to accurately, unobtrusively, non-invasively, and objectively detect and quantify various sleep behaviours, disturbances, and disorders.

Conditions

  • Pregnancy Related
  • Sleep
  • Sleep-Disordered Breathing
  • Sleep Disturbance
  • Sleep Disorder

Interventions

  • Infrared video-audio cameraDevice

    Wyze Cam V2 by Wyze Labs, Inc., Seattle, USA

  • Level III home sleep apnea testDevice

    NightOwl® by Ectosense, Leuven, Belgium

  • Maternal-fetal transabdominal electrocardiographic heart rate monitorDevice

    The Monica AN24 Antenatal Fetal Holter by Monica Healthcare, Nottingham, UK

  • Pressure sensing matDevice

    Tactilus® V Series Mattress Pressure Monitoring System by Sensor Products Inc., Madison, USA

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maternal supine sleep positionTime frame: 4 nights (approximately 32 hours)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Toronto

    Toronto, Ontario, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.